Instrumento Inactivo

Otros idiomas Protalix Biotherapeutics Inc TEL AVIV STOCK EXCHANGE

Acciones

US74365A1016

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Protalix BioTherapeutics : PLX Corporate Presentation (June 2024)	28/06
Protalix BioTherapeutics : KOL Presentation Prof Aleš Linhart Fabry	28/06
Protalix BioTherapeutics : Submission of Matters to a Vote of Security Holders Form 8 K	28/06
Protalix BioTherapeutics to Present at the 2024 BIO International Convention	30/05
Protalix BioTherapeutics : PLX Corporate Presentation (May 2024)	20/05
Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business Results	13/05
Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05
Earnings Flash (PLX) PROTALIX BIOTHERAPEUTICS Reports Q1 Revenue $3.7M, vs. Street Est of $9.2M	10/05
Protalix: Q1 Earnings Snapshot	10/05
Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024	06/05
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results	15/03
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024	08/03
Protalix BioTherapeutics to Participate in the 2024 BIO CEO and Investor Conference	26/02
Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results	07/11
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	06/11
Protalix: Q3 Earnings Snapshot	06/11
Earnings Flash (PBDA) PROTALIX BIOTHERAPEUTICS Reports Q3 Revenue $10.3M	06/11
Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023	31/10/23
Protalix BioTherapeutics : PLX Corporate Presentation (October 2023)	23/10/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Protalix Biotherapeutics Inc TEL AVIV STOCK EXCHANGE

Acciones

US74365A1016

Otros idiomas

Filtros